Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ePoster Display

1127P - Cancer and Age Research Group (CARG) predicting chemotherapy toxicity in elderly patients with cancer

Date

16 Sep 2021

Session

ePoster Display

Topics

Cancer in Older Adults

Tumour Site

Presenters

Dalila Miraoui

Citation

Annals of Oncology (2021) 32 (suppl_5): S921-S930. 10.1016/annonc/annonc707

Authors

D. Miraoui1, D. Yekrou2, S. Ghomari3, N. Chabni3

Author affiliations

  • 1 Medicine, Centre Anti Cancer SBA, 13000 - Tlemcen/DZ
  • 2 Medicine, Centre Anti Cancer SBA, 22000 - Sidi Bel Abbès/DZ
  • 3 Medicine, Universite Abou Bakr Belkaid, 13000 - Tlemcen/DZ

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 1127P

Background

Oncogeriatrics is a discipline that combines the skills of oncology and geriatrics to serve elderly patients with cancer. In the absence of geriatrician in our country, it would be useful in the current situation to try to introduce in our daily practice some elements of the global geriatric assessment (CGA) like the CARG predictive score of chemotoxicity. The present study aimed to verify feasibility and compare the value of CARG score with the results of chemotoxicity.

Methods

A prospective study was conducted in old patients with cancer. Before chemotherapy treatment, a geriatric assessment was done and the CARG score was calculated for each patient. The chemotherapy-related toxicity was collected on the basis of the National Cancer Institute Common Terminology Criteria for Adverse Events (CTCAE; version 4.0). The results of the CARG score were compared with the toxicity described by the patients.

Results

One hundred and forty-two patients were treated with chemotherapy. Mean age was 71 years. Colorectal cancer (34.7%) was the most common localization followed by lung cancer (31.9%). 100 patients have one or two comorbidities of which 90 were taking less than 3 medications. Most patients (57%) had a good ECOG performance statute (ECOG PS 1). Patients were in low, intermediate and high-risk of severe chemotherapy toxicity in 14.5; 51.5 and 30% respectively. 1067 chemotherapy treatment according to 48 chemotherapy protocols were administered. 75% of cases of patients received a poly chemotherapy. Severe toxicity (grade 3-5) were noted in 82 patients. The most common grade 3-5 non-haematological toxicities were fatigue (43), diarrhea (32) and anorexia (27). The hematological toxicities (grade 3-5) were leukopenia (32) and neutropenia (64). For the CARG toxicity score, rates of severe adverse events in low, intermediate and high-risk groups were 11.8%, 33.3% and 15.5 % respectively. The frequency of severe chemotherapy toxicity in the different risk groups according to the CARG toxicity scores were independent there was no statistically significant association between them, χ2=0.68; p=0.71.

Conclusions

In our study the CARG toxicity predictive tool could not effectively estimate the occurrence of severe toxicity related to chemotherapy.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

Miraoui Dalila.

Funding

Has not received any funding.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.